Cytoprotective agent in Lactobacillus bulgaricus extracts

Current Microbiology

Volumn 54, Issue 2, 2007, Pages 131-135

  Johns, Paul ^a   Pereira, Suzette L ^a   Leonard, Amanda E ^a   Mukerji, Pradip ^a   Shalwitz, Robert A ^a   Dowlati, Lobat ^a   Phillips, Rosalyn R ^a   Bergana, Marti S ^a   Holton, Jason D ^a   Das, Tapas ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEPTIDOGLYCAN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL CELL WALL; BACTERIUM; BIOLOGICAL ACTIVITY; CELL ASSAY; CELL PROTECTION; CYTOTOXICITY; DRUG HYDROLYSIS; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG ISOLATION; DRY WEIGHT; GRAM POSITIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LACTOBACILLUS BULGARICUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ADENOSINE DIPHOSPHATE RIBOSE; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXIMIDE; EPITHELIAL CELLS; LACTOBACILLUS; LUNG; MAGNETIC RESONANCE SPECTROSCOPY; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; POSIBACTERIA;

EID: 33846305091     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-006-0256-6     Document Type: Article

References (25)

1. Amano K, Williams JC (1983) Peptidoglycan of Legionella pneumophila: apparent resistance with a high degree of cross-linking. J Bacteriol 153(1):520-526
2. Amrouche T, Boutin Y, Prioult G, Fliss I (2005) Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production. Int Dairy J 16:70-80
3. Bausserman M, Michail S (2005) The use of Lactobacillus GG in irritable bowel syndrome in children: A double-blind randomized control trial. J Pediatr 147(2):197-201
4. Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR (2002) Increased mucosal tumour necrosis factor-α production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51:659-664
5. Cho YS, Han MK, Kwark OS, Phoe MS, Cha YS, An NH, Kim UH (1998) Auto- ADP-ribosylation of NAD glycohydrolase from Neurospora crassa. Comp Biochem Physiol B 120:175-181
6. Commane D, Hughes R, Shortt C, Rowland I (2005) The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res 591:276-289
7. Georgieva P, Ivanovska N, Barot-Ciorbaru R (1998) Immunomodulatory properties of Nocardia lysozyme digest (NLD) in complement normal and C5-deficient mice. Vaccine 16:1237-1242
8. Ghosh S, van Heel D, Playford RJ (2004) Probiotics in inflammatory bowel disease: Is it all gut flora modulation? Gut 53:620-622
9. Lin H, Su B, Chen A, Lin TW, Tsai C, Yeh T (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115:1-4
10. Liyan Z, Qingxiao Z, Zuowei L, Hanming R (2004) Effects of reaction conditions on lysozymic hydrolysis of partially N-acetylated chitosans. Int Food Technol Annu Meet Poster 93-93
11. Merkel GJ, Scofield BA (2001) Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments. Clin Diag Lab Immunol 8(3):647-651
12. Miller G, Lou L, Nakamura A (1998) Method and composition for inhibiting cellular irreversible changes due to stress. U.S. Patent 5,801,159; September 1, 1998
13. Miwa M, Saito H, Sakura H, Saikawa N, Watanabe F, Matsushima T, Sugimura T (1977) A 13C NMR study of poly(adenosine diphosphate ribose) and its monomers: evidence of alpha-(1″→2′)ribofuranosyl ribofuranoside residue. Nucleic Acids Res 4:3997-4005
14. Neu J, Caicedo R (2005) Probiotics: Protecting the intestinal ecosystem? J Pediatr 147(2):143-146
15. O'Sullivan DJ (2001) Screening of intestinal microflora for effective probiotic bacteria. J Agric Food Chem 49:1751-1760
16. Pereyra BS, Falcoff R, Falcoff E, Lemonnier D (1991) Interferon induction by Lactobacillus bulgaricus and Streptococcus thermophilus in mice. Eur Cytokine Netw 2(4):299-303
17. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB (2004) Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gasteroenterol 127:1474-1487
18. Reid T, Louie P, Heller RA (1994) Mechanisms of tumor necrosis factor cytotoxicity and the cytotoxic signals transduced by the p75-tumor necrosis factor receptor. Circ Shock 44(2):84-90
19. Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM (2005) Probiotic and other functional microbes: From markets to mechanisms. Curr Opin Biotechnol 16:204-211
20. Schrijver IA, van Meurs M, Melief MJ, Wim Ang C, Buljevac D, Ravid R, Hazenberg MP, Laman JD (2001) Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 124:1544-1554
21. Sheil B, McCarthy J, O'Mahony L, Bennett MW, Ryan P, Fitzgibbon JJ, Kiely B, Collins JK, Shanahan F (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53:694-700
22. Sonis ST (2004) The pathobiology of mucositis. Nature Reviews 4:277-284
23. Xu M, Wang Z, Locksley RM (2004) Innate immune responses in peptidoglycan recognition protein L-deficient mice. Mol Cell Biol 24(18):7949-7957
24. Yamazaki M, Sakuda S, Torida Y (1999) Oral immunity enhancing agent containing peptidoglycans. Eur Patent Applic EP0941736A1; September 15, 1999
25. Zhang L, Li N, Caicedo R, Neu J (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-α-induced interleukin-8 production in Caco-2 cells. J Nutr 135:1752-1756